EMA — authorised 11 November 2016
- Marketing authorisation holder: Amgen Europe B.V.
- Status: approved
🇪🇺 Parsabiv in European Union
EMA authorised Parsabiv on 11 November 2016
Marketing authorisation
Parsabiv in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in European Union
Frequently asked questions
Is Parsabiv approved in European Union?
Yes. EMA authorised it on 11 November 2016.
Who is the marketing authorisation holder for Parsabiv in European Union?
Amgen Europe B.V. holds the EU marketing authorisation.